L01FC01 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
63特発性血小板減少性紫斑病1

63. 特発性血小板減少性紫斑病


臨床試験数 : 391 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2019-004683-22-DK
(EUCTR)
12/07/202217/05/2022Daratumumab as a treatment for adult immune thrombocytopeniaDaratumumab as a treatment for adult immune thrombocytopenia - The DART-study Immune thrombocytopenia
MedDRA version: 23.0;Level: LLT;Classification code 10021245;Term: Idiopathic thrombocytopenic purpura;System Organ Class: 100000004851;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
Trade Name: Darzalex
Product Name: Daratumumab
Product Code: L01FC01
INN or Proposed INN: DARATUMUMAB
Other descriptive name: HUMAX-CD38
Ostfold Hospital TrustNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
21Phase 2Denmark;Norway